Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Neurotransmitters norepinephrine serotonin

All of the major psychedelic drugs have a close chemical resemblance to the neurotransmitters norepinephrine, serotonin, and dopamine. [Pg.251]

However, the exact problem in CNS amine neurotransmission remains a subject of much debate. One leading theory is that depression may be caused by an increased sensitivity of the presynaptic or postsynaptic receptors for these transmitters. That is, the neurochemistry of the brain has been changed in some way to make the amine receptors more sensitive to their respective amine neurotransmitters (norepinephrine, serotonin, and to a lesser extent, dopamine).21 This theory is based primarily on the finding that antidepressant drugs prolong the activity of amine neurotransmission in the brain, thereby causing a compensatory decrease in the sensitivity of the amine receptors.21,47... [Pg.78]

The physiological action of antidepressants is not fully understood. However, they are thought to influence the metabolism, reuptake, or selective receptor antagonism of the neurotransmitters serotonin and norepinephrine. The MAOIs cause an increase of the neurotransmitters norepinephrine, serotonin, and dopamine in the brain by inhibiting their breakdown. The SSRIs prevent the reabsorbtion of serotonin, one of the 50-odd neurotransmitters in the brain. [Pg.56]

Catecholamine—Monoamines such as the neurotransmitters norepinephrine, serotonin, and dopamine that are synthesized from the amino acid, tyrosine, and have similar structures. Conditioned reflex—response in which one stimulus, the conditioned one, is associated with and elicits the same response as another stimulus, the unconditioned stimulus. [Pg.534]

The effects of amphetamines are due to the increase of neurotransmitters norepinephrine, serotonin, and dopamine in central synapses. This increase is from increased release and reuptake blockade of catecholamines. Amphetamines may also inhibit monoamine oxidase. These mechanisms combine to produce the sympathomimetic and central nervous system (CNS) effects seen with amphetamine abuse. [Pg.108]

How it works Blocks reuptake of neurotransmitters (norepinephrine, serotonin) at presynaptic membranes,... [Pg.239]

Stimulants are drugs that excite the central nervous system. They stimulate production of the neurotransmitters norepinephrine, serotonin, and dopamine in the brain, heart (which is stimulated to beat faster), and veins (which become constricted). Note the similarity in the structures of amphetamine and methamphetamine to epinephrine and norepinephrine (Section 17.5), which helps to explain their action. [Pg.443]

Monoamine Oxidase Inhibitors. MAOIs inactivate the enzyme MAO, which is responsible for the oxidative deamination of a variety of endogenous and exogenous substances. Among the endogenous substances are the neurotransmitters, norepinephrine, dopamine, and serotonin. The prototype MAOI is iproniazid [54-92-2] (25), originally tested as an antitubercular dmg and a close chemical relative of the effective antitubercular, isoniazid [54-85-3] (26). Tubercular patients exhibited mood elevation, although no reHef of their tuberculosis, following chronic administration of iproniazid. In... [Pg.465]

Neurotransmitters are molecules that convey a signal from one nerve cell to the other. Neurotransmitters can be biogenic amines (e.g. norepinephrine, serotonin),... [Pg.842]

O Classic views as to the cause of major depressive disorder focus on the monoamine neurotransmitters norepinephrine (NE), serotonin (5-HT), and to a lesser extent, dopamine (DA) in terms of both synaptic concentrations and receptor functioning. [Pg.569]

In the vertebrate CNS monoamines have been associated with a number of physiological functions (reviewed in Kandel et al., 1991). Serotonin has functions associated with mood, pain, sleep, learning, and memory. Dopamine has functions associated with schizophrenia, Parkinson s disease, and cocaine addiction. In vertebrates, dopamine is further metabolized into two additional neurotransmitters, norepinephrine and epinephrine. Norepinephrine increases the excitability of cells in response to sudden sensory input such as fear. Epinephrine has been identified in specific neurons of the brain, but the function of these cells is unknown. In addition, AADC has also been found in a class of neurons that do not have any of the four neurotransmitters discussed above (Jaeger et al., 1983). These neurons may use one of the trace amines, tyramine, tryptamine, or phenylethylamine, as a neurotransmitter. [Pg.60]

Iproniazid and imipramine seemed to work as antidepressants, but how did they achieve their effects It would be another decade before the chemical-imbalance theory was launched. In 1965, Joseph Schildkraut at the National Institute of Mental Health in Washington, DC, published a groundbreaking paper in which he argued that depression was caused by a deficiency of the neurotransmitter norepinephrine in the gaps between neurons in the brain.8 Two years later Alec Coppen, a physician at West Park Hospital in Surrey, published another version of the chemical-imbalance theory. His version differed from Schildkraut s in that it put most of the blame on a different neurotransmitter, emphasizing serotonin rather than norepinephrine as the neurotransmitter that was lacking.9... [Pg.85]

But that was only one half of the logic behind the chemical-imbalance theory. The other half came from studies of reserpine, a drug that was extracted from Rauvolfia serpentina or the Indian snakeroot plant, which had historically been used to treat snakebite, hypertension, insomnia and insanity. In studies of animals, reserpine was reported to induce sedation and to decrease brain levels of norepinephrine, serotonin and dopamine. Clinical reports indicated that some people became severely depressed when taking reserpine.14 Putting these two findings together, it seemed likely that reserpine made people depressed because it decreased neurotransmitter levels. [Pg.87]

Figure 3.2 Normally, when the stomach is full it sends a signal to the brain telling the body to stop eating. This message is carried by neurotransmitters (chemical messengers in the brain) to the hunger center in the hypothalamus (a part of the brain). Examples of neurotransmitters that carry this message are norepinephrine, serotonin, and dopamine. Many diet pills increase these same neurotransmitters that signal the brain that the stomach is full. These diet pills, called appetite suppressants, trick the brain into thinking the stomach is full and therefore decrease hunger. Figure 3.2 Normally, when the stomach is full it sends a signal to the brain telling the body to stop eating. This message is carried by neurotransmitters (chemical messengers in the brain) to the hunger center in the hypothalamus (a part of the brain). Examples of neurotransmitters that carry this message are norepinephrine, serotonin, and dopamine. Many diet pills increase these same neurotransmitters that signal the brain that the stomach is full. These diet pills, called appetite suppressants, trick the brain into thinking the stomach is full and therefore decrease hunger.
Histaminergic neurons can regulate and be regulated by other neurotransmitter systems. A number of other transmitter systems can interact with histaminergic neurons (Table 14-1). As mentioned, the H3 receptor is thought to function as an inhibitory heteroreceptor. Thus, activation of brain H3 receptors decreases the release of acetylcholine, dopamine, norepinephrine, serotonin and certain peptides. However, histamine may also increase the activity of some of these systems through H, and/or H2 receptors. Activation of NMDA, p opioid, dopamine D2 and some serotonin receptors can increase the release of neuronal histamine, whereas other transmitter receptors seem to decrease release. Different patterns of interactions may also be found in discrete brain regions. [Pg.261]

It may be that any peripherally adversive stimulus — especially one that stimulates sympathetic activity — thus has the potential to activate brain areas of prime importance in the formation of anxiety symptoms. As a result of pharmacological challenge studies, biochemical assays, neuroimaging and studies of animal models, a number of centrally acting neurotransmitters, and their relevant neural circuits, are implicated in anxiety. These neurotransmitters include norepinephrine, serotonin, GABA, neuropeptide Y, cholecystokin and substance P. [Pg.902]

The numerous effects of Li+ upon the neurotransmitters [146,147] and their membrane receptors [148] have been reviewed recently. Li+ affects processes involved with the synthesis of, release of, reuptake of, and receptor activation by neurotransmitters in both animals and humans. In terms of the neurotransmitter amines, serotonin appears to be most affected by Li+, whereas the effects upon dopamine and norepinephrine are small. [Pg.28]

Mice exposed for 28 days to phenol in drinking water exhibited a significant reduction in dopamine level in the corpus striatum at the 1.8 mg/kg/day dose, and significantly decreased levels of norepinephrine, serotonin, and 5-hydroxyindoleacetic acid in the hypothalamus at the 6.2 mg/kg/day dose (Hsieh et al. 1992). Levels of neurotransmitters in other brain regions were also significantly altered at higher doses of phenol. [Pg.75]

Monoamine Oxidase Inhibitors (MAOIs). As mentioned earlier, the MAOIs are excellent treatments for both depression and anxiety. They act by increasing neurotransmission of three neurotransmitter systems serotonin, norepinephrine. [Pg.333]

The mechanism of antidepressive action of this series of drugs is likely associated with their inhibition of the oxidizing deamination process of the neurotransmitters norepinephrine, epinephrine, dopamine, and serotonin, which participate in the transmission of nerve excitement in the CNS. A major drawback of these drugs is the high toxicity associated with their inhibition of not only MAO, but also a number of other nonspecific enzymes. [Pg.110]

Mechanism of Action An MAOI that inhibits the activity of the enzyme monoamine oxidase at CNS storage sites, leading to increased levels of the neurotransmitters epinephrine, norepinephrine, serotonin, and dopamine at neuronal receptor sites. Therapeutic Effect Relieves depression. [Pg.970]

Cocaine inhibits the presynaptic reuptake of the neurotransmitters norepinehrine, serotonin, and dopamine at synaptic junctions. This results in increased concentrations in the synaptic cleft. Since norepinephrine acts within the sympathetic nervous system, increased sympathetic stimulation is produced. Physiological effects of this stimulation include tachycardia, vasoconstriction, mydriasis, and hyperthermia.3 CNS stimulation results in increased alertness, diminished appetite, and increased energy. The euphoria or psychological stimulation produced by cocaine is thought to be related to the inhibition of serotonin and dopamine reuptake. Cocaine also acts as a local anesthetic due to its ability to block sodium channels in neuronal cells.3... [Pg.39]

An example of negative allosteric modulation is the case of the antidepressants, which act as neurotransmitter reuptake blockers for the neurotransmitters norepinephrine and serotonin. This has already been discussed in Chapter 2. When the neurotransmitters norepinephrine and serotonin bind to their own selective receptor sites, they are normally transported back into the presynaptic neuron, as shown in Figure 2-23- Thus the empty reuptake carrier (Fig. 2—20) binds to the neurotransmitter (Fig. 2—21) to begin the transport process (Fig. 2—23). However, when certain antidepressants bind to an allosteric site close to the neurotransmitter transporter (represented as an icon in Figs. 2—22 and 2—24), this causes the neurotransmitter to no longer be able to bind there, thereby blocking synaptic re-... [Pg.94]

Obsessive-compulsive disorder may be linked to abnormalities of the neurotransmitters serotonin and dopamine. The neuroanatomical basis of OCD may be related to dysfunction in the basal ganglia. The hallmark of treatment for OCD is use of SSRIs plus the tricyclic antidepressant clomipramine. Panic disorder is characterized by unexpected panic attacks, possibly linked to abnormalities in the neurotransmitters norepinephrine and GABA, in the sensitivity of benzodiazepine receptors, or even in the regulation of respiration. Drag treatments include SSRIs, several of the newer antidepressants, high-potency benzodiazepines, many tricyclic antidepressants, and MAO inhibitors. [Pg.364]

In addition to the cholinergic deficit, Alzheimer s disease has also been shown to be characterized by marked deficits in the monoamine neurotransmitters norepinephrine and serotonin, as well as in glutamate and some neuropeptide neurotransmitters (Figure 27.6). [Pg.305]

The active ingredient of St. John s wort is a substance called hyperforin. Like other antidepressants, hyperforin appears to work by helping to restore the proper balance to brain chemistry. In particular, hyperforin helps restore the balance of certain neurotransmitters, or chemical messengers, in the brain. These neurotransmitters include serotonin, norepinephrine, and dopamine. [Pg.231]


See other pages where Neurotransmitters norepinephrine serotonin is mentioned: [Pg.41]    [Pg.41]    [Pg.316]    [Pg.65]    [Pg.570]    [Pg.178]    [Pg.61]    [Pg.35]    [Pg.49]    [Pg.41]    [Pg.237]    [Pg.166]    [Pg.139]    [Pg.686]    [Pg.126]    [Pg.127]    [Pg.680]    [Pg.538]    [Pg.539]    [Pg.87]    [Pg.409]    [Pg.696]   


SEARCH



Neurotransmitters Norepinephrine

Norepinephrine

Serotonin neurotransmitter

Serotonin-norepinephrine

© 2024 chempedia.info